MRSA

MRSA is a bacterium responsible for several difficult-to-treat infections in humans.


Info

Technology Platform

Zenon Biosystem use Existing and Leading Technology to develop a cost effective device in the MRSA detection.

Info

Zenosense MRSA detector

Zenon intends to develop a cost effective system that acts like a “Presence Alarm” for MRSA/SA.


Info

Development Team

A Highly Specialised, Experienced Team. Together, the team have over 15 years of experience.


Info

ZENON BIOSYSTEM

A specialist Unit with a Single Objective

Zenon Biosystem is a specialist Spanish company focused on developing a Methicillin-resistant Staphylococcus aureus (“MRSA”) detection device to be developed for use in hospitals.

MRSA is a bacterium responsible for several difficult-to-treat infections in humans. MRSA is a particular danger in clinical settings, such as hospitals and care homes.

There is currently no cost effective system that acts like a “Detector Alarm” for MRSA/SA, detecting infection early, in the patient or in the rooms of a healthcare building.

Zenon is developing unique technology to produce exactly such a device, utilizing a specialist team of scientists, mathematicians and engineers.

Zenon is a part of the Sgenia Group, a leading European sensor developer. Zenon is developing a “Zenosense MRSA Sensor” in collaboration with Zenosense Inc., a U.S. company who will have an exclusive, worldwide license on the resulting products, subject to certain limitations and a royalty arrangement on a revenue sharing basis with Zenon.

MRSA

Early Detection
MRSA
  • A critical problem
  • A expensive Problem
  • Leading Technology
  • Existing Technology
  • High qualified Team